SCHEMBL23733894

SCHEMBL23733894

Fc1cccc(-c2nc(-c3ccc(-c4ccc(-c5cccnc5)cc4)cc3)nc(-c3cccc(F)c3)n2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGDS O60760 1/20 0.53
ABL1 P00519 1/20 0.53
BCR P11274 1/20 0.53
ABCG2 Q9UNQ0 2/20 0.49
CYP2A6 P11509 4/20 0.48
CYP3A4 P08684 2/20 0.48
ALDH1A1 P00352 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP11B1 P15538 3/20 0.48
CYP17A1 P05093 2/20 0.47
CYP11B2 P19099 2/20 0.47
CYP19A1 P11511 1/20 0.47
TAAR1 Q96RJ0 1/20 0.47
TP53 P04637 1/20 0.47
MKNK1 Q9BUB5 4/20 0.46
MKNK2 Q9HBH9 4/20 0.46
BCHE P06276 1/20 0.46
ACHE P22303 1/20 0.46
MEN1 O00255 1/20 0.45
PSIP1 O75475 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23733784 0.87 CYP11B1 (0.51) ABL1BCRABCG2CYP2A6CYP3A4
SCHEMBL26077645 0.86 CYP11B2 (0.58) CYP2A6CYP3A4ALDH1A1CYP1A2CYP11B1
SCHEMBL23733880 0.85 CYP19A1 (0.50) ABL1BCRCYP2A6CYP3A4ALDH1A1
SCHEMBL8225016 0.84 CYP2A6 (0.62) HPGDSABL1BCRCYP2A6CYP3A4
SCHEMBL18327354 0.83 CYP19A1 (0.59) CYP2A6CYP3A4ALDH1A1CYP1A2CYP11B1
SCHEMBL21982129 0.83 CYP19A1 (0.59) CYP2A6CYP3A4ALDH1A1CYP1A2CYP11B1
SCHEMBL19039944 0.83 CYP19A1 (0.59) CYP2A6CYP3A4ALDH1A1CYP1A2CYP11B1
SCHEMBL18327447 0.83 CYP19A1 (0.59) CYP2A6CYP3A4ALDH1A1CYP1A2CYP11B1
SCHEMBL23733839 0.83 TAAR1 (0.57) HPGDSABCG2ALDH1A1TAAR1TP53
SCHEMBL28880094 0.83 TAAR1 (0.57) HPGDSABCG2ALDH1A1TAAR1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11844273-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-12-12 US disclosed
US-11844273-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-12-12 US disclosed
US-11563183-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-01-24 US disclosed
US-20210367158-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-11-25 US disclosed
US-11088331-B2 2021-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11563183-B2 Heterocyclic compound and organic light-emitting device including the same DDT, PPOX, LEF1 HPGDS 3790/4885ABL1 1621/4885BCR 1226/4885
US-11844273-B2 Heterocyclic compound and organic light-emitting device including the same DDT, PPOX, LEF1 HPGDS 3790/4885ABL1 1621/4885BCR 1226/4885
US-11088331-B2 DDT, PPOX, DBF4 HPGDS 4389/4885ABL1 1206/4885BCR 1471/4885
US-20210367158-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME DDT, PPOX, LEF1 HPGDS 3790/4885ABL1 1621/4885BCR 1226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.